Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

TransEnterix, Inc.

TRXDWPNK
Healthcare
Medical - Specialties
$0.15
$-0.02(-11.76%)
U.S. Market opens in 9h 44m

TransEnterix, Inc. Fundamental Analysis

TransEnterix, Inc. (TRXDW) shows weak financial fundamentals with a PE ratio of -0.48, profit margin of -9.14%, and ROE of -1.18%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position56.25%
PEG Ratio-0.00
Current Ratio2.88

Areas of Concern

ROE-1.18%
Operating Margin-9.11%
We analyze TRXDW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -969.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-969.8/100

We analyze TRXDW's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRXDW struggles to generate sufficient returns from assets.

ROA > 10%
-1.30%

Valuation Score

Excellent

TRXDW trades at attractive valuation levels.

PE < 25
-0.48
PEG Ratio < 2
-0.00

Growth Score

Weak

TRXDW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TRXDW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.17
Current Ratio > 1
2.88

Profitability Score

Weak

TRXDW struggles to sustain strong margins.

ROE > 15%
-117.89%
Net Margin ≥ 15%
-9.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is TRXDW Expensive or Cheap?

P/E Ratio

TRXDW trades at -0.48 times earnings. This suggests potential undervaluation.

-0.48

PEG Ratio

When adjusting for growth, TRXDW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values TransEnterix, Inc. at 1.12 times its book value. This may indicate undervaluation.

1.12

EV/EBITDA

Enterprise value stands at -0.69 times EBITDA. This is generally considered low.

-0.69

How Well Does TRXDW Make Money?

Net Profit Margin

For every $100 in sales, TransEnterix, Inc. keeps $-9.14 as profit after all expenses.

-9.14%

Operating Margin

Core operations generate -9.11 in profit for every $100 in revenue, before interest and taxes.

-9.11%

ROE

Management delivers $-1.18 in profit for every $100 of shareholder equity.

-1.18%

ROA

TransEnterix, Inc. generates $-1.30 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.30%

Following the Money - Real Cash Generation

Operating Cash Flow

TransEnterix, Inc. generates limited operating cash flow of $-68.11M, signaling weaker underlying cash strength.

$-68.11M

Free Cash Flow

TransEnterix, Inc. generates weak or negative free cash flow of $-68.71M, restricting financial flexibility.

$-68.71M

FCF Per Share

Each share generates $-0.26 in free cash annually.

$-0.26

FCF Yield

TRXDW converts -1.60% of its market value into free cash.

-1.60%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.48

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.12

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.67

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.17

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.88

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.18

vs 25 benchmark

ROA

Return on assets percentage

-1.30

vs 25 benchmark

ROCE

Return on capital employed

-1.63

vs 25 benchmark

How TRXDW Stacks Against Its Sector Peers

MetricTRXDW ValueSector AveragePerformance
P/E Ratio-0.4829.45 Better (Cheaper)
ROE-117.89%779.00% Weak
Net Margin-914.46%-24936.00% (disorted) Weak
Debt/Equity0.170.26 Strong (Low Leverage)
Current Ratio2.884.65 Strong Liquidity
ROA-129.57%-19344.00% (disorted) Weak

TRXDW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TransEnterix, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ